MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 233 filers reported holding MYRIAD GENETICS INC in Q4 2015. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $523,000 | -66.4% | 26,426 | -77.9% | 0.00% | -72.7% |
Q3 2020 | $1,558,000 | +1.4% | 119,488 | -11.8% | 0.01% | -8.3% |
Q2 2020 | $1,537,000 | +11.1% | 135,542 | +40.2% | 0.01% | -14.3% |
Q1 2020 | $1,384,000 | -55.6% | 96,690 | -15.5% | 0.01% | -39.1% |
Q4 2019 | $3,117,000 | +3.0% | 114,452 | +8.3% | 0.02% | -4.2% |
Q3 2019 | $3,026,000 | -8.0% | 105,672 | -10.8% | 0.02% | -11.1% |
Q2 2019 | $3,290,000 | -2.5% | 118,440 | +16.5% | 0.03% | -3.6% |
Q1 2019 | $3,375,000 | -41.7% | 101,633 | -49.0% | 0.03% | -42.9% |
Q4 2018 | $5,789,000 | -37.6% | 199,159 | -1.3% | 0.05% | -18.3% |
Q3 2018 | $9,282,000 | -22.6% | 201,796 | -37.1% | 0.06% | -25.0% |
Q2 2018 | $11,990,000 | +10.6% | 320,876 | -12.6% | 0.08% | +207.7% |
Q1 2018 | $10,843,000 | -15.2% | 366,969 | -1.4% | 0.03% | -13.3% |
Q4 2017 | $12,780,000 | -12.3% | 372,103 | -7.6% | 0.03% | -11.8% |
Q3 2017 | $14,578,000 | +182.7% | 402,876 | +101.9% | 0.03% | +142.9% |
Q2 2017 | $5,157,000 | +26.1% | 199,553 | -6.3% | 0.01% | +27.3% |
Q1 2017 | $4,089,000 | +60.7% | 213,044 | +39.6% | 0.01% | +57.1% |
Q4 2016 | $2,544,000 | -25.5% | 152,626 | -8.1% | 0.01% | -36.4% |
Q3 2016 | $3,417,000 | -30.8% | 166,046 | +2.9% | 0.01% | -31.2% |
Q2 2016 | $4,940,000 | -15.0% | 161,437 | +3.9% | 0.02% | -11.1% |
Q1 2016 | $5,814,000 | -37.9% | 155,313 | -28.4% | 0.02% | -33.3% |
Q4 2015 | $9,364,000 | -8.4% | 216,953 | -20.4% | 0.03% | -12.9% |
Q3 2015 | $10,222,000 | -18.4% | 272,704 | -26.0% | 0.03% | 0.0% |
Q2 2015 | $12,528,000 | +1.9% | 368,565 | +6.1% | 0.03% | +6.9% |
Q1 2015 | $12,299,000 | +20.6% | 347,384 | +16.0% | 0.03% | +11.5% |
Q4 2014 | $10,198,000 | -23.5% | 299,373 | -13.4% | 0.03% | -18.8% |
Q3 2014 | $13,326,000 | +4.9% | 345,505 | +5.9% | 0.03% | 0.0% |
Q2 2014 | $12,704,000 | +35.9% | 326,398 | +19.4% | 0.03% | +18.5% |
Q1 2014 | $9,346,000 | +59.2% | 273,342 | -2.3% | 0.03% | +50.0% |
Q4 2013 | $5,869,000 | -0.8% | 279,716 | +11.1% | 0.02% | -14.3% |
Q3 2013 | $5,916,000 | +12.1% | 251,705 | +28.1% | 0.02% | -4.5% |
Q2 2013 | $5,278,000 | – | 196,428 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |